Safety, Tolerability and Pharmacokinetics of AD16 Tablets in Adult Healthy Subjects After Single Administration
Clinical trial NCT05787028 · COMPLETED
Trial details
- NCT number
- NCT05787028
- Sponsor
- South China Center For Innovative Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2020-05-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.